We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
(+9.1%)
Cap. Flow
-$256M
Cap. Flow
% of AUM
-0.25%
Top 10 Holdings %
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$35.4M |
| 2 |
P
Everpure Inc
P
|
+$21M |
| 3 |
NVIDIA
NVDA
|
+$20.7M |
| 4 |
American Homes 4 Rent
AMH
|
+$19.3M |
| 5 |
DAY
Dayforce
DAY
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$46.7M |
| 2 |
Apple
AAPL
|
+$41.8M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$32.3M |
| 4 |
Gilead Sciences
GILD
|
+$27.8M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$25.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.42% |
| 2 | Financials | 13.09% |
| 3 | Healthcare | 11.94% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Industrials | 9.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1476
Ligand Pharmaceuticals
LGND
$6.28B
| $4.4M | ﹤0.01% |
60,255
+730
| +1% | +$53.8K |
|
1477
Red Rock Resorts
RRR
$3.59B
| $4.4M | ﹤0.01% |
73,517
+418
| +0.6% | +$23.2K |
|
1478
Mercury Insurance
MCY
$6B
| $4.39M | ﹤0.01% |
85,151
-623
| -0.7% | -$27.5K |
|
1479
Schrodinger
SDGR
$1.39B
| $4.39M | ﹤0.01% |
162,550
+981
| +0.6% | +$27.4K |
|
1480
CTS Corp
CTS
$1.86B
| $4.38M | ﹤0.01% |
93,558
-22
| -0% | -$965 |
|
1481
Pacira BioSciences
PCRX
$969M
| $4.37M | ﹤0.01% |
149,598
+693
| +0.5% | +$21.3K |
|
|
CERE
1482
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $4.36M | ﹤0.01% |
103,190
+8,893
| +9% | +$374K |
|
1483
Goosehead Insurance
GSHD
$2.3B
| $4.34M | ﹤0.01% |
65,099
-383
| -0.6% | -$29.3K |
|
1484
Shift4
FOUR
$3.19B
| $4.32M | ﹤0.01% |
65,369
-5,670
| -8% | -$426K |
|
1485
Harmonic Inc
HLIT
$1.27B
| $4.29M | ﹤0.01% |
319,134
+40
| +0% | +$510 |
|
|
SPR
1486
DELISTED
Spirit AeroSystems
SPR
| $4.29M | ﹤0.01% |
118,812
-17,840
| -13% | -$541K |
|
1487
SAP
SAP
$239B
| $4.28M | ﹤0.01% |
21,955
+963
| +5% | +$171K |
|
1488
Uranium Energy
UEC
$5.62B
| $4.28M | ﹤0.01% |
634,253
-50,984
| -7% | -$360K |
|
1489
Ultragenyx Pharmaceutical
RARE
$2.6B
| $4.28M | ﹤0.01% |
91,663
-9,002
| -9% | -$425K |
|
1490
Q2 Holdings
QTWO
$3.91B
| $4.27M | ﹤0.01% |
81,266
+1,081
| +1% | +$48.9K |
|
1491
Lindsay Corp
LNN
$1.17B
| $4.24M | ﹤0.01% |
36,069
+1,016
| +3% | +$126K |
|
1492
Extreme Networks
EXTR
$3.13B
| $4.23M | ﹤0.01% |
366,941
-5,318
| -1% | -$72.5K |
|
1493
IDEAYA Biosciences
IDYA
$3.58B
| $4.23M | ﹤0.01% |
96,410
+10,444
| +12% | +$449K |
|
1494
Rapid7
RPD
$768M
| $4.23M | ﹤0.01% |
86,209
+1,613
| +2% | +$88.5K |
|
|
PPLI
1495
People Inc
PPLI
$3.05B
| $4.22M | ﹤0.01% |
96,396
-12,651
| -12% | -$546K |
|
1496
Kratos Defense & Security Solutions
KTOS
$11.6B
| $4.21M | ﹤0.01% |
228,967
+19,566
| +9% | +$356K |
|
1497
Apogee Enterprises
APOG
$886M
| $4.21M | ﹤0.01% |
71,031
-419
| -0.6% | -$23.2K |
|
1498
Impinj
PI
$5.43B
| $4.19M | ﹤0.01% |
32,652
+855
| +3% | +$89.8K |
|
1499
Omnicell
OMCL
$1.7B
| $4.18M | ﹤0.01% |
142,907
+210
| +0.1% | +$6.37K |
|
1500
FB Financial Corp
FBK
$3.04B
| $4.18M | ﹤0.01% |
110,869
+12
| +0% | +$441 |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2024 Portfolio in Review
As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
- RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
- RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
- RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
- RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
- RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
- RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.
Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.